Menu

Request a Free Mesothelioma Information Guide

  • Information on top doctors and cancer centers
  • The latest clinical trials and treatment methods
  • Financial information to help with treatment costs
Request a Free Guide
HomeTreatmentClinical TrialsClinical Trials – Completed

There are four phases that mesothelioma clinical trials go through. In Phase I new mesothelioma drugs or treatments are tested in a small group of participants. Phase II evaluates the same drug or treatment therapy in a larger group. Phase III involves an even larger population of participants and Phase IV takes place post licensing and marketing of a new drug or treatment. The clinical trials listed below have completed. Please click on a link to learn more about the study and the study results.

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies


Conditions: Lung Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Carcinoma, Non-Small-Cell Lung

Last Updated: September 27, 2019

Status: Completed

Mithramycin for Lung, Esophagus, and Other Chest Cancers


Conditions: Mesothelioma, Gastrointestinal Neoplasms, Digestive System Neoplasms

Last Updated: September 24, 2019

Status: Completed

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 23, 2019

Status: Completed

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas


Conditions: Sarcoma, Esophageal Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms, Neoplasms

Last Updated: September 21, 2019

Status: Completed

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma


Conditions: Mesothelioma

Last Updated: September 19, 2019

Status: Completed

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: September 3, 2019

Status: Completed

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Pleural Effusion

Last Updated: August 5, 2019

Status: Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)


Conditions: Neoplasms

Last Updated: July 16, 2019

Status: Completed

Malignant Mesothelioma - Can we Improve Quality of Life


Conditions: Mesothelioma

Last Updated: June 12, 2019

Status: Completed

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma


Conditions: Adenocarcinoma, Mesothelioma, Pancreatic Neoplasms, Adenocarcinoma of Lung

Last Updated: June 5, 2019

Status: Completed

E-MOSAIC Electronic Tool to Monitor Symptoms


Conditions:

Last Updated: May 14, 2019

Status: Completed

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 16, 2019

Status: Completed

╬▒DC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pancreatic Neoplasms, Neoplasms

Last Updated: April 11, 2019

Status: Completed

CART-meso in Mesothelin Expressing Cancers


Conditions: Adenocarcinoma, Mesothelioma, Carcinoma, Ovarian Epithelial

Last Updated: February 22, 2019

Status: Completed

Chest Wall Motion Analysis in Disease


Conditions: Empyema, Empyema, Pleural, Mesothelioma, Lung Neoplasms, Funnel Chest, Pectus Carinatum, Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive

Last Updated: February 21, 2019

Status: Completed

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program


Conditions: Carcinoma, Carcinoma, Renal Cell, Mesothelioma, Carcinoma, Transitional Cell, Intestinal Neoplasms, Gastrointestinal Neoplasms

Last Updated: January 10, 2019

Status: Completed

18F-FSPG PET/CT for Cancer Patients on Therapy


Conditions: Breast Neoplasms, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

Last Updated: December 11, 2018

Status: Completed

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms, Neoplasms

Last Updated: December 11, 2018

Status: Completed

WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy


Conditions: Mesothelioma

Last Updated: November 1, 2018

Status: Completed

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2018

Status: Completed

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Parathyroid Neoplasms, Pleural Neoplasms, Thyroid Neoplasms, Pneumothorax, Thyroid Diseases, Neoplasms

Last Updated: July 20, 2018

Status: Completed

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 11, 2018

Status: Completed

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)


Conditions: Colonic Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Ovarian Epithelial, Mesothelioma, Germinoma, Ovarian Neoplasms, Lung Neoplasms, Pseudomyxoma Peritonei

Last Updated: July 2, 2018

Status: Completed

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: June 12, 2018

Status: Completed

A Study in Non Small Cell Lung Cancer


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung

Last Updated: May 16, 2018

Status: Completed

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 4, 2018

Status: Completed

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy


Conditions: Mesothelioma

Last Updated: March 13, 2018

Status: Completed

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2017

Status: Completed

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: December 27, 2017

Status: Completed

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors


Conditions: Mesothelioma

Last Updated: November 27, 2017

Status: Completed

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma


Conditions: Mesothelioma

Last Updated: November 3, 2017

Status: Completed

Autologous Redirected RNA Meso-CIR T Cells


Conditions: Mesothelioma

Last Updated: September 16, 2017

Status: Completed

Nivolumab in Patients With Recurrent Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 13, 2017

Status: Completed

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)


Conditions: Mesothelioma

Last Updated: July 17, 2017

Status: Completed

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.


Conditions: Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms

Last Updated: July 6, 2017

Status: Completed

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: June 8, 2017

Status: Completed

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)


Conditions: Mesothelioma

Last Updated: April 24, 2017

Status: Completed

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: April 5, 2017

Status: Completed

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 27, 2017

Status: Completed

Thrombin Generation and Platelet Activation in CRS/HIPEC


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei

Last Updated: January 24, 2017

Status: Completed

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 10, 2017

Status: Completed

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: December 5, 2016

Status: Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases


Conditions: Rare Diseases

Last Updated: November 16, 2016

Status: Completed

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: November 4, 2016

Status: Completed

Collecting Tumor Samples From Patients With Gynecological Tumors


Conditions: Carcinoma, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Rhabdomyosarcoma, Germinoma, Leiomyosarcoma, Vulvar Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Cystadenocarcinoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Cystadenocarcinoma, Serous, Carcinoma, Adenosquamous, Brenner Tumor, Sarcoma, Endometrial Stromal, Rhabdomyosarcoma, Embryonal, Neoplasms

Last Updated: October 26, 2016

Status: Completed

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers


Conditions: Mesothelioma

Last Updated: September 28, 2016

Status: Completed

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 16, 2016

Status: Completed

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study


Conditions: Mesothelioma

Last Updated: September 1, 2016

Status: Completed

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays


Conditions: Mesothelioma

Last Updated: July 25, 2016

Status: Completed

Capecitabine in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 12, 2016

Status: Completed

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 11, 2016

Status: Completed

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 30, 2016

Status: Completed

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)


Conditions: Mesothelioma

Last Updated: May 29, 2016

Status: Completed

Tomotherapy Treatment for Mesothelioma


Conditions: Mesothelioma

Last Updated: April 5, 2016

Status: Completed

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma


Conditions: Leukemia, Lung Neoplasms, Preleukemia, Mesothelioma, Myelodysplastic Syndromes, Syndrome

Last Updated: February 2, 2016

Status: Completed

B-Receptor Signaling in Cardiomyopathy


Conditions: Carcinoma, Multiple Myeloma, Sarcoma, Urinary Bladder Neoplasms, Mesothelioma, Neuroendocrine Tumors, Cholangiocarcinoma, Gastrointestinal Stromal Tumors, Hodgkin Disease, Carcinoma, Transitional Cell, Anus Neoplasms, Lymphoma, Non-Hodgkin, Testicular Neoplasms, Bone Neoplasms, Gallbladder Neoplasms, Eye Neoplasms, Thymus Neoplasms, Brain Neoplasms, Endocrine Gland Neoplasms, Carcinoma, Renal Cell, Stomach Neoplasms, Cardiomyopathies, Myelodysplastic Syndromes, Myeloproliferative Disorders, Amyloidosis

Last Updated: November 16, 2015

Status: Completed

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: November 16, 2015

Status: Completed

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 13, 2015

Status: Completed

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer


Conditions: Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

Last Updated: October 28, 2015

Status: Completed

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy


Conditions: Mesothelioma, Colonic Neoplasms, Peritoneal Neoplasms, Abdominal Neoplasms, Neoplasms

Last Updated: October 19, 2015

Status: Completed

Intrapleural Gene Transfer for Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 21, 2015

Status: Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma


Conditions: Lymphoma

Last Updated: July 7, 2015

Status: Completed

Isolated Thoracic Perfusion (ITP-F) for MPM


Conditions: Mesothelioma

Last Updated: June 9, 2015

Status: Completed

Immunotoxin Therapy in Treating Patients With Advanced Cancer


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms

Last Updated: April 29, 2015

Status: Completed

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Head and Neck Neoplasms, Uterine Cervical Neoplasms, Mesothelioma, Fallopian Tube Neoplasms

Last Updated: April 29, 2015

Status: Completed

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura


Conditions: Lung Neoplasms, Esophageal Neoplasms, Mesothelioma

Last Updated: April 28, 2015

Status: Completed

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 11, 2015

Status: Completed

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 28, 2015

Status: Completed

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2014

Status: Completed

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients


Conditions: Mesothelioma

Last Updated: December 1, 2014

Status: Completed

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 25, 2014

Status: Completed

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation


Conditions: Melanoma, Small Cell Lung Carcinoma, Colorectal Neoplasms, Ovarian Neoplasms, Liposarcoma, Neoplasms

Last Updated: July 23, 2014

Status: Completed

A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Ovarian Neoplasms, Mesothelioma

Last Updated: July 16, 2014

Status: Completed

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 5, 2014

Status: Completed

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite


Conditions: Mesothelioma

Last Updated: March 4, 2014

Status: Completed

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 26, 2014

Status: Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 10, 2014

Status: Completed

Rapamycin With Grapefruit Juice for Advanced Malignancies


Conditions: Neoplasm Metastasis

Last Updated: January 16, 2014

Status: Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain


Conditions: Cancer Pain

Last Updated: January 14, 2014

Status: Completed

Serum Biomarkers in Diagnosis of Mesothelioma


Conditions: Mesothelioma

Last Updated: January 6, 2014

Status: Completed

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms, Postoperative Complications

Last Updated: December 18, 2013

Status: Completed

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: August 6, 2013

Status: Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors


Conditions: Carcinoma, Sarcoma, Liver Neoplasms, Mesothelioma, Nervous System Neoplasms, Central Nervous System Neoplasms, Pheochromocytoma, Adrenocortical Carcinoma

Last Updated: July 9, 2013

Status: Completed

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer


Conditions: Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Mesothelioma, Kidney Neoplasms

Last Updated: July 9, 2013

Status: Completed

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 27, 2013

Status: Completed

Alanosine in Treating Patients With Cancer


Conditions: Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Mesothelioma

Last Updated: June 25, 2013

Status: Completed

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 4, 2013

Status: Completed

SU5416 in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: May 31, 2013

Status: Completed

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: April 16, 2013

Status: Completed

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)


Conditions: Mesothelioma, Fever

Last Updated: March 15, 2013

Status: Completed

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 23, 2013

Status: Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction


Conditions: Carcinoma, Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Pancreatic Neoplasms, Glioblastoma, Rectal Neoplasms, Glioma, Head and Neck Neoplasms, Colonic Neoplasms, Uterine Cervical Neoplasms, Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Astrocytoma, Carcinoma, Ovarian Epithelial, Mesothelioma, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Carcinoma, Verrucous, Carcinoma, Basal Cell, Ependymoma, Gliosarcoma, Salivary Gland Neoplasms, Oligodendroglioma, Papilloma, Nasopharyngeal Carcinoma, Paranasal Sinus Neoplasms, Anus Neoplasms, Carcinoma, Adenoid Cystic, Neoplasms, Unknown Primary, Breast Neoplasms, Male, Carcinoma, Mucoepidermoid, Esthesioneuroblastoma, Olfactory, Papilloma, Inverted, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Laryngeal Diseases, Granuloma, Neoplasms

Last Updated: January 15, 2013

Status: Completed

Gefitinib in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: January 15, 2013

Status: Completed

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)


Conditions: Mesothelioma

Last Updated: December 19, 2012

Status: Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 30, 2012

Status: Completed

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: October 5, 2012

Status: Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen


Conditions: Colorectal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Anus Neoplasms, Gallbladder Neoplasms

Last Updated: July 27, 2012

Status: Completed

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 17, 2012

Status: Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: July 17, 2012

Status: Completed

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 5, 2012

Status: Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung


Conditions: Mesothelioma

Last Updated: May 14, 2012

Status: Completed

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: March 14, 2012

Status: Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma


Conditions: Lymphoma

Last Updated: March 14, 2012

Status: Completed

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma


Conditions: Mesothelioma

Last Updated: December 23, 2011

Status: Completed

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors


Conditions:

Last Updated: September 26, 2011

Status: Completed

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer


Conditions:

Last Updated: April 23, 2011

Status: Completed

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 25, 2011

Status: Completed

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: February 25, 2011

Status: Completed

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment


Conditions: Mesothelioma

Last Updated: November 17, 2010

Status: Completed

Dendritic Cell-based Immunotherapy in Mesothelioma


Conditions: Mesothelioma

Last Updated: November 15, 2010

Status: Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.


Conditions: Carcinoma, Sarcoma, Mesothelioma, Breast Neoplasms, Endometrial Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Esophageal Neoplasms, Testicular Neoplasms, Small Cell Lung Carcinoma, Carcinoma, Neuroendocrine

Last Updated: August 2, 2010

Status: Completed

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: June 10, 2010

Status: Completed

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2009

Status: Completed

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma


Conditions: Mesothelioma, Pleural Neoplasms

Last Updated: May 1, 2009

Status: Completed

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy


Conditions: Pleural Effusion, Pleural Diseases

Last Updated: July 22, 2008

Status: Completed

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 5, 2007

Status: Completed

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 10, 2007

Status: Completed

Written By

Linda Molinari Editor in Chief

Linda Molinari has more than 15 years of experience as a writer and advocate for mesothelioma patients and a ban on asbestos.


Full Bio Editorial Guidelines
Reviewed By

Annette Charlevois Patient Support Coordinator

Annette Charlevois is a senior paralegal at the law firm of Early, Lucarelli, Sweeney & Meisenkothen, helping patients find medical and legal resources.


Full Bio

Get Help Contacting


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe